| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement
|
Coltro, Giacomo
|
|
|
141 |
20 |
p. 2541
|
article
|
| 2 |
A new CAR takes a test drive in DLBCL
|
Abramson, Jeremy S.
|
|
|
141 |
20 |
p. 2410-2411
|
article
|
| 3 |
Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A
|
Gonzalez-Menendez, Pedro
|
|
|
141 |
20 |
p. 2520-2536
|
article
|
| 4 |
CD8+ T-cell clones in immune thrombocytopenia
|
|
|
|
141 |
20 |
p. 2543
|
article
|
| 5 |
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
|
Dunbar, Andrew J.
|
|
|
141 |
20 |
p. 2508-2519
|
article
|
| 6 |
DNA or RNA? Classification of B-cell lymphomas
|
Ylstra, Bauke
|
|
|
141 |
20 |
p. 2413-2415
|
article
|
| 7 |
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
|
Roddie, Claire
|
|
|
141 |
20 |
p. 2470-2482
|
article
|
| 8 |
Editorial Board
|
|
|
|
141 |
20 |
p. vi
|
article
|
| 9 |
Fresh blood without stem?
|
Elfassy, Erez
|
|
|
141 |
20 |
p. 2411-2413
|
article
|
| 10 |
How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy
|
Gutierrez, Cristina
|
|
|
141 |
20 |
p. 2452-2459
|
article
|
| 11 |
How I treat cytopenias after CAR T-cell therapy
|
Jain, Tania
|
|
|
141 |
20 |
p. 2460-2469
|
article
|
| 12 |
How I treat refractory CRS and ICANS after CAR T-cell therapy
|
Jain, Michael D.
|
|
|
141 |
20 |
p. 2430-2442
|
article
|
| 13 |
How I treat unique and difficult-to-manage cases of CAR T-cell therapy–associated neurotoxicity
|
Santomasso, Bianca D.
|
|
|
141 |
20 |
p. 2443-2451
|
article
|
| 14 |
Introduction to a How I Treat series on emergent CAR T-cell toxicities
|
Heslop, Helen E.
|
|
|
141 |
20 |
p. 2405-2407
|
article
|
| 15 |
Masthead Subscription
|
|
|
|
141 |
20 |
p. i
|
article
|
| 16 |
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
|
Alduaij, Waleed
|
|
|
141 |
20 |
p. 2493-2507
|
article
|
| 17 |
Regeneration after blood loss and acute inflammation proceeds without contribution of primitive HSCs
|
Munz, Clara M.
|
|
|
141 |
20 |
p. 2483-2492
|
article
|
| 18 |
Romiplostim drug presence in pregnancy and lactation
|
Labrecque, Audrey Ann
|
|
|
141 |
20 |
p. 2537-2540
|
article
|
| 19 |
Shelter from the cytokine storm in myelofibrosis
|
Lane, Steven W.
|
|
|
141 |
20 |
p. 2415-2416
|
article
|
| 20 |
Table of Contents
|
|
|
|
141 |
20 |
p. iii-v
|
article
|
| 21 |
TEMRA: the CD8 subset in chronic ITP?
|
Lazarus, Alan H.
|
|
|
141 |
20 |
p. 2409-2410
|
article
|
| 22 |
The role of CD8+ T-cell clones in immune thrombocytopenia
|
Malik, Amna
|
|
|
141 |
20 |
p. 2417-2429
|
article
|
| 23 |
Trinh BQ, Ummarino S, Zhang Y, et al. Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML. Blood. 2021;138(15):1331-1344.
|
|
|
|
141 |
20 |
p. 2542
|
article
|
Journal description